Improving access to clinical trials
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to be part of one.
Expanding trial access – ICR report
Our 2021 report, Clinical trials in cancer, reveals the impact of the Covid-19 pandemic on cancer trials and highlights longstanding barriers to expanding clinical trial access to more people with cancer. But Covid-19 also offers clues to a recovery that can get new treatments to cancer patients more quickly.
![Empty lab 547x410](/images/default-source/migrated/default-library/empty-lab-547x410.jpg?sfvrsn=1741d2e9_2)
News: Cancer trial recruitment drops by 60 per cent during pandemic
The number of cancer patients entering clinical trials has plummeted during the pandemic – denying many thousands the latest treatment options and delaying drug development. Here, cancer experts set out their findings about the barriers to carrying out clinical trials in the UK and proposals for boosting participation.Latest ICR News
![Green cells are melanoma cells, purple fibres are ECM_credit Oscar Maiques Carlos Human melanoma cells are seen in green escaping from the tumour, with surrounding ECM in purple, arranged perpendicular to the tumour](/images/default-source/appius-qa-test-images/green-cells-are-melanoma-cells-purple-fibres-are-ecm_credit-oscar-maiques-carlos.jpg?sfvrsn=c8f05a8e_1)
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escape
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body.
![Brisken - 3d reconstruction of the human breast 945x532 3d reconstruction of the human breast](/images/default-source/migrated/default-library/brisken---3d-reconstruction-of-the-human-breast-945x532.jpg?sfvrsn=cfc04778_2)
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions.
![DNA art DNA art](/images/default-source/migrated/default-library/dna-art.png?sfvrsn=37efe3e8_2)
Scientists show that the immune system indirectly influences the genes that drive cancer
Researchers have uncovered new details about the complex relationship between the immune system and cancer.
![Breast cancer cells Credit Ewa Krawczyk 945x532 Breast cancer cells Credit Ewa Krawczyk 945x532](/images/default-source/migrated/default-library/breast-cancer-cells-credit-ewa-krawczyk-945x532.jpg?sfvrsn=2342ea79_2)
Breast cancer risk model provides reassuring data for those with family history of disease after short-term HRT use
Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk model published in the British Journal of General Practice.